Su, Shao-Hua <br/><br/>
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling.  [electronic resource] 

 -  Behavioural brain research  10 2016 
 - 334-344 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-7549 
<br/><br/><label>Standard No.: </label>10.1016/j.bbr.2016.07.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzamides--pharmacology<br/>Benzoxazines--pharmacology<br/>Cannabinoid Receptor Agonists--pharmacology<br/>Carbamates--pharmacology<br/>Cognitive Dysfunction--drug therapy<br/>Fatty Acids--metabolism<br/>Glycogen Synthase Kinase 3--metabolism<br/>Long-Term Potentiation--drug effects<br/>Male<br/>Maze Learning--physiology<br/>Mixed Function Oxygenases--antagonists & inhibitors<br/>Morpholines--pharmacology<br/>Naphthalenes--pharmacology<br/>Neuroprotective Agents--pharmacology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Rats, Sprague-Dawley<br/>Receptors, Cannabinoid--drug effects<br/>Signal Transduction--drug effects